Freeze-dried platelet product may aid clotting in severe thrombocytopenia
A freeze-dried platelet-derived product improved clotting in blood samples from patients with severe thrombocytopenia.
A freeze-dried platelet-derived product improved clotting in blood samples from patients with severe thrombocytopenia.
A Serbian study confirmed anti-HPA-1a is the most prevalent antibody in FNAIT, adding evidence to previous findings across Europe.
A study showed that early maternal genetic testing and IVIG therapy can prevent brain bleeding in infants during high-risk FNAIT pregnancies.
AI can improve blood donation and patient care, but experts emphasize the need for ethical safeguards and human oversight to ensure safety.